Julio Jesús Garcia-Coste

Mr. Julio Jesús Garcia-Coste

orcid
Escuela Superior de Medicina, Instituto Politécnico Nacional

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Julio Jesús Garcia-CosteJulio Jesús Garcia-Coste
Julio Jesús Garcia-Coste
SVSantiago Villafaña-Rauda
Santiago Villafaña-Rauda
KCKARLA AIDEE AGUAYO CERON
KARLA AIDEE AGUAYO CERON
CVCruz Vargas-De-León
Cruz Vargas-De-León
RRRodrigo Romero-Nava
Rodrigo Romero-Nava
This study investigated the relationship between the transcription factors (TFs) KLF14 and SREBF-1 and orphan receptors (ORs) in the context of metabolic syndrome (MetS). A detailed bioinformatics analysis identified a significant association between the presence of binding sites (BS) for these TFs in the promoters of ORs genes and the total number of BS in the distal region. The results suggest that KLF14 and SREBF-1 can regulate the expression of some of these genes and, in turn, can modulate the development of MetS. Although a stronger association was observed with KLF14, both factors showed a significant contribution. Additionally, the sequence similarity of KLF14 also contributed to the quantity of BS in the gene’s distal region (DR). The statistical models used, such as Poisson and negative binomial regression, confirmed these associations and allowed for the appropriate adjustment of overdispersion present in the data. However, no significant differences in receptor groups (orphan G Protein-Coupled Rereptors (oGPCRs) and G Protein-Coupled Receptors associated with MetS (GPCRs-MetS)) regarding their relationship with TFs were found. In conclusion, this study provides strong evidence of the importance of KLF14 and SREBF-1 in regulating orphan receptors genes and their participation in the development of metabolic syndrome.

9 March 2026 in Medical Sciences
Verified
Journal Article
Open access
PDF file
Julio Jesús Garcia-CosteJulio Jesús Garcia-Coste
Julio Jesús Garcia-Coste
KCKARLA AIDEE AGUAYO CERON
KARLA AIDEE AGUAYO CERON
JEJudith Espinosa-Raya
Judith Espinosa-Raya
AGAlexis Alejandro García-Rivero
Alexis Alejandro García-Rivero
CLCarina López
Carina López
RRRodrigo Romero-Nava
Rodrigo Romero-Nava
Background: Conventional omics analysis often treats outliers as noise, yet they may harbor critical biological insights. Objetive: This study proposes a paradigm shift: actively investigating outliers to discover biologically relevant subtypes within metabolic–inflammatory syndromes. Methods: We applied a comprehensive analytical framework for outlier detection based on a multi-algorithm consensus (IQR, MAD, Isolation Forest) to a clinical cohort of diabetic neuropathy (n = 93) and an in vitro 3T3-L1 adipocyte model (n = 39). The identified outliers were characterized using robust PCA, co-expression networks, unsupervised clustering, and Random Forest predictive modeling. Results: In the clinical cohort, an outlier subgroup (47.3%) exhibited an extreme immune–metabolic phenotype characterized by hyperactivation of Th1/Th17 pathways (elevated T-bet and IL-17; p < 0.001), hypertriglyceridemia, and network reconfiguration (TGFβ and STAT4 hubs). In the cellular model, outlier samples (12.8%) showed autonomous pro-inflammatory behavior characterized by IL-6 overproduction (p = 0.002) and IL-10 suppression. Conclusions: Multivariate analysis confirmed spatial segregation of these profiles. Systematic outlier investigation revealed discrete pathophysiological subtypes invisible to mean-focused analyses, demonstrating that extreme values encapsulate potent biological signals. This framework offers a generalizable approach for uncovering clinical heterogeneity and identifying therapeutic targets in complex diseases.

16 September 2026 in Life
Verified
Journal Article
Open access
PDF file
CECarlos Uriel Uriel Torres Estrella
Carlos Uriel Uriel Torres Estrella
JAJOSE LUIS ACOSTA
JOSE LUIS ACOSTA
Julio Jesús Garcia-CosteJulio Jesús Garcia-Coste
Julio Jesús Garcia-Coste
Fausto Sanchez-MunozFausto Sanchez-Munoz
Fausto Sanchez-Munoz
RRRodrigo Romero-Nava
Rodrigo Romero-Nava
KCKarla Aidee Aguayo Cerón
Karla Aidee Aguayo Cerón
Adipogenesis is crucial for maintaining energy homeostasis, as it facilitates the differentiation of mesenchymal stem cells into adipocytes. This process is transcriptionally regulated by key factors including PPARγ and C/EBPβ, alongside FABP4 during lipogenesis. However, it is now well established that a significant portion of this regulation is also mediated by small non-coding RNAs (miRNAs) and long non-coding RNAs (lncRNAs), which post-transcriptionally modulate gene expression. This study aimed to identify key miRNAs involved in adipogenesis and to determine how Aloe-emodin, a molecule with potent anti-inflammatory properties known to modulate adipocyte differentiation, alters their expression. Using an integrative approach combining 3T3-L1 cell culture, RNA-seq, and qPCR analyses, this study demonstrates that Aloe-emodin can upregulate transcription factors (PPARγ and C/EBPβ) as well as miR-143 and miR-155, suggesting its potential as a modulator of adipogenic gene or miRNA expression in this exploratory setting.